ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

ACS Division Help Fund Some CIS Offices

September 13, 1985

In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident

April 30, 1976

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

NCI Clinical Alert Urges Patients To Seek Care From Specialists.

January 20, 2006